1. 1458Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience. (28th August 2018) Authors: Forslund, T; Komen, J J; Andersen, M; Wettermark, B; Von Euler, M; Mantel-Teeuwisse, A K; Braunschweig, F; Hjemdahl, P Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe. (3rd October 2022) Authors: De Vries, T A C; Pecen, L; Komen, J J; Diemberger, I; Fumagalli, S; De Groot, J R; Kirchhof, P; De Caterina, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe. (3rd October 2022) Authors: De Vries, T A C; Pecen, L; Komen, J J; De Groot, J R; Kirchhof, P; De Caterina, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗